April 15th 2025
When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.
April 11th 2025
Why taking proactive steps—and combing the right data sources—is critical to informed decision-making in risk management.
April 9th 2025
Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.
February 7th 2025
Introducing a new Pharma Commerce column focused on combating illicit trade and protecting product integrity—and ultimately patients.
January 20th 2025
Despite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial intelligence and predictive forecasting.
Report: Track-and-Trace Solutions Market Anticipated to Hit $9.8 Billion by 2028
The predicted value is largely driven by manufacturers' prioritization of brand protection.
P360 Builds Out New Artificial Intelligence-Powered Platform
EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information.
The Importance of Drug Supply Chain Security
JAMA Health Forum details the DSCSA and stresses the value of protecting the pharmaceutical supply chain from adulterated products.
Top 3 Podcast Episodes of the Year
This year’s PC Podcast episodes ranged in topic, from DSCSA compliance to pharmacovigilance.
ACG Inspection Presents New VRS
Cloud-based service to address verification of saleable returns under the latest DSCSA regulations.
Trade & Channel Strategies 2023: A DSCSA Update
The seminar examines where members of the pharma supply chain stand in terms of preparation, being that the act has officially been enacted.
A Supply Chain Overhaul
Back in Boston, Pharma Commerce tackles all things logistics at LogiPharma USA.
The Power of Centralized Distribution in the Face of DSCSA Compliance
With new mandates right around the corner, there is an unwavering demand for pharma operations to perform at peak efficiency.
Anti-Counterfeit Packaging Market Estimated to Reach Nearly $436 Million by 2030
Value is attributed to the rise in counterfeit cases and ongoing regulations surrounding anti-counterfeit packaging.
FDA Offers 12-Month DSCSA Stabilization Period, but Urges Industry Not to Delay
A breakdown on the decision, and how to navigate these obstacles using a network approach.
LogiPharma USA 2023: Impactful Roundtable Discussions
Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.
LogiPharma USA 2023: Tracy Nasarenko Discusses Final Thoughts and More GS1 US
Tracy Nasarenko offers her final thoughts on DSCSA implementation guidelines at LogiPharma USA 2023.
LogiPharma USA 2023: Tracy Nasarenko Discusses the GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3
Sr. Director of Community Engagement for Pharmaceuticals at GS1 US explains what the implementation guidelines are meant to accomplish.
LogiPharma USA 2023: Tracy Nasarenko Discusses Steps Pharma Supply Should Take to Adapt to New DSCSA Laws
GS1 US Executive provides insight on how pharma supply can speed up the process of complying with regulations.
LogiPharma USA 2023: Tracy Nasarenko Provides a Synopsis of “DSCSA—Final Checks to Have Before Deadlines.”
In an interview at LogiPharma USA 2023 with Pharma Commerce Editor Nicholas Saraceno, Tracy Nasarenko, Sr. Director of Community Engagement for Pharmaceuticals, GS1 US highlights her “DSCSA—Final Checks to Have Before Deadlines.”
LogiPharma USA 2023: Making a List and Checking It Twice
LogiPharma session reminds attendees of what to review, as far as DSCSA compliance is concerned.
Drilling Down On Distribution
Pharma Commerce converges on Nation's Capital for HDA Traceability Seminar.
Counterfeit Meds: Fighting the Forgers
Questions and considerations for pharmaceutical companies in designing and executing strategies to curb the incidence of fake drugs.
HDA 2023 Traceability Seminar: A Status Update
Stakeholders uncover the obstacles surrounding the industry onboarding process.
HDA 2023 Traceability Seminar: DSCSA Roundtable Discussions
Attendees meet to discuss operational issues related to traceability implementation.
HDA 2023 Traceability Seminar: DSCSA Areas of Improvement
Session offers information on industry readiness, plus an overview of a phase implementation recommendation.
HDA 2023 Traceability Seminar: An FDA DSCSA Overview
Event’s first session aims to analyze the legislation’s implementation, as FDA enforcement is delayed until November 2024.
MatchRX, LSPedia Collaborate on FDA-DSCSA Compliance Solution
Software allows pharmacies to meet legislation’s upcoming Nov. 27 deadline.
DSCSA: A Fast-Approaching Deadline
The legislation’s deadline for compliance is knocking on the door. Pharma Commerce offers a synopsis of how the Drug Supply Chain Security Act has progressed over the past decade.
TraceLink Hosts Conference Centered Around E2E Supply Chain Visibility
DSCSA compliance was also top of mind at the event.
Videojet Launches New Laser Marking Systems for Pharma Industry
The series’ marking heads help deliver codes to support both product traceability and anti-counterfeiting efforts.
DSCSA Compliance Readiness Inches Along, Says HDA Survey
Latest Q4 2022 results show some progress, but 100% readiness by November looks doubtful.
Ramping Up DSCSA Readiness Efforts
As a November deadline looms for industry compliance with an interoperable system for product tracing, there is more urgency in the US pharma supply chain.
FDA Finalizes the Definitions of 'Suspect and Illegitimate' Pharma Products
Industry is still scrambling to handle clerical errors of DSCSA transactions.
HDA’s 2023 Distribution Management Conference Dives into DSCSA Specifics and More
Event—taking place in Indianapolis—places supply chain education at the forefront.